www.ioptima.com Open in urlscan Pro
52.206.163.162  Public Scan

Form analysis
0 forms found in the DOM

Text Content

About Us
Our Products
IOPtiMate®Fabilas™iLid™Lipitear™ Multi
Treatments
GlaucomaEyelid Surgery Skin ResurfacingOcular Surface Disorder
Resources
Live SurgeriesClinical StudiesTestimonials
For DistributorsNewsPitch an IdeaContact




IOPTIMA IS DEDICATED TO IMPROVING OPHTHALMIC CARE THROUGH THE DEVELOPMENT AND
COMMERCIALIZATION OF INNOVATIVE PRODUCTS ADDRESSING A WIDE RANGE OF OCULAR
CONDITIONS

Glaucoma
Oculoplasty
Ocular Surface Disorder
Experience the New



OUR PRODUCTS


IOPTIMATE®

GLAUCOMA SURGERY

The IOPtimate® is a surgical system for treating glaucoma which utilizes CO2
laser technology to significantly reduce the intraocular pressure (IOP) by
restoring the natural fluid percolation without penetrating the eye.


Learn More



ILID™

OCULOPLASTY – SKIN RESURFACING

The iLid™ CO2 laser kit is a more precise alternative to manual surgical
scalpels for oculoplasty Surgeons to incise the upper and/or lower eyelids and
remove excess fat. The iLid™ also has a handpiece that can be used for skin
resurfacing, resulting in younger-looking skin for patients.

Learn More



LIPITEAR™ MULTI

OCULAR SURFACE DISORDER

Lipitear™ Multi is a unique, innovative, preservative-free, vegan lipid-based
microemulsion formula for the relief of all common symptoms of ocular surface
disorder such as dryness, irritation, grittiness, burning, and stinging.

Lipitear™ Multi, phospholipid microemulsion for ophthalmic use, is indicated for
reducing dry eye symptoms.

Learn More



FABILAS™

GLAUCOMA – OCULOPLASTY – SKIN RESURFACING

Fabilas™ is a one-of-a-kind surgical platform that allows physicians to perform
a variety of ocular treatments for different indications with high precision and
safety.
‍Launching soon

Learn More



OUR LATEST NEWS


Read all news

GLAUCOMA - 5 MYTHS DEBUNKED

Debunking myths and having the facts about glaucoma is essential to protect and
preserve eye health.

HOW TO MANAGE DRY EYE DISEASE

July is Dry Eye Awareness Month, so IOPtima would like to present the first
advertisements for the only preservative-free lipid-based eye drops, LIPITEAR™
MULTI, that are currently already available in Israel.

ANNOUNCING ERAN KAPLAN AS NEW CEO OF IOPTIMA

We’re pleased to announce that we have appointed Eran Kaplan as new Chief
Executive Officer of IOPtima. Eran's appointment is a clear reflection of the
company’s current state: ready to take on the future and fired up. IOPtima is
poised for an innovation and expansion in the Laser based Ophthalmic market and
we’re excited what Eran's unique experience in the field.


WHAT THE EXPERTS SAY


PROF. EHUD ASSIA

MEIR MEDICAL CENTER, KFAR SABA, ISRAEL - INVENTOR

The eye is normally quiet and the patient's vision returns to normal soon after
surgery. Fluid percolation is constantly assessed during surgery, and if needed,
further laser ablations may be applied until a satisfactory clinical result is
achieved. The CLASS learning curve is fast.


PROF. ANDRE MERMOUD

CLINIQUE DE MONTCHOISI, LAUSANNE, SWITZERLAND

IOPtima’s CLASS procedure has true advantages over trabeculectomy surgery as it
offers an excellent safety profile with ease of use. It can lower pressure into
the lower teens and reduce the patient’s reliance on glaucoma medications
without subjecting the eye to the risks of trabeculectomy. It also reduces the
learning curve for performing deep sclerectomy with very similar results to
published data.


DR. MUÑOZ GONZALO

HOSPITAL NISA VALENCIA AL MAR, VALENCIA, SPAIN

In my experience, patient follow-up over 24 months demonstrates consistent and
sustained IOP reduction. The efficacy and simplicity of the IOPtiMate® procedure
is remarkable.


DR. FÉLIX GIL CARRASCO

HOSPITAL ANGELES DEL PEDREG, MEXICO CITY, MEXICO

From my experience using IOPtima’s CLASS, the procedure (1) is effective in
lowering IOP, (2) is easy to use with a short learning curve, (3) has a high
safety profile due to a its laser qualities and (4) reduces post-op recovery and
complications associated with other penetrating surgeries.


DR. NIR SHOHAM-HAZON

BARZILAI UNIVERSITY HOSPITAL, ASHKELON, ISRAEL

There’s no other glaucoma surgery that maintains an untouched anterior chamber.
In standalone case, not even a side port incision is needed. Hence, speedy
recovery, no anterior chamber inflammation and least chances of cataract
formation. Once you go CLASS you never go TRAB.







TAKE YOUR CLINIC TO THE NEXT LEVEL!
TO SCHEDULE A DEMO, CONTACT US.

Contact us


IOPtima is dedicated to improving ophthalmic care through the development and
commercialization of innovative products for a wide range of ocular conditions.

IOPtima is a Chengdu Kanghong Pharmaceutical company.

Read More
Our Products
IOPtimate®Fabilas™iLid™Lipitear™
Treatments
GlaucomaEyelid SurgerySkin ResurfacingOcular Surface Disorder
Pitch an Idea

IOPtima, along with our parent company, Kanghong Pharmaceuticals, is working
with companies, researchers and doctors around the world with a mission to bring
the most advanced, safe and effective products to the ophthalmic community. We
invite you to partner with us on this important mission. Contact us if you have
an innovative product, idea or are looking to partner for the development or
commercialization of your product.


Contact Us


Privacy • Terms • All Right Reserved 2022  • Made by BRACT Agency